A decade of reversal: An analysis of 146 contradicted medical practices

Mayo Clinic Proceedings

Volumn 88, Issue 8, 2013, Pages 790-798

  Prasad, Vinay ^a   Vandross, Andrae ^b   Toomey, Caitlin ^c   Cheung, Michael ^d   Rho, Jason ^c   Quinn, Steven ^e   Chacko, Satish Jacob ^c   Borkar, Durga ^c   Gall, Victor ^e   Selvaraj, Senthil ^c   Ho, Nancy ^f   Cifu, Adam ^g  

^a NATIONAL CANCER INSTITUTE   (United States)

^b YALE UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d LANKENAU INSTITUTE FOR MEDICAL RESEARCH   (United States)

^e GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; APROTININ; GENTAMICIN; METHYLPREDNISOLONE; ROFECOXIB; VALACICLOVIR;

ADJUVANT THERAPY; ARTICLE; BACTERIURIA; BREAST CANCER; CLINICAL RESEARCH; COLORECTAL CANCER; CORONARY ARTERY DISEASE; FERTILIZATION IN VITRO; HEALTH CARE; HORMONAL THERAPY; HUMAN; INDUCED HYPOTHERMIA; INFECTION; INTRACRANIAL ANEURYSM; KNEE ARTHROPLASTY; MEDICAL LITERATURE; MEDICAL PRACTICE; MYRINGOTOMY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PUBLICATION; RISK BENEFIT ANALYSIS; STANDARD; TYMPANOSTOMY TUBE; VESTIBULAR NEURONITIS;

EID: 84884673223     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2013.05.012     Document Type: Article

References (94)

1. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15): 1503-1516.
2. Rossouw JE, Anderson GL, Prentice RL, et al; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3): 321-333.
3. Sandham JD, Hull RD, Brant RF, et al; Canadian Critical Care Clinical Trials Group. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med. 2003;348(1): 5-14.
4. Prasad V, Gall V, Cifu A. The frequency of medical reversal. Arch Intern Med. 2011;171(18):1675.
5. Prasad V, Cifu A, Ioannidis JPA. Reversals of established medical practices: evidence to abandon ship. JAMA. 2012;307(1): 37-38.
6. Prasad V, Cifu A. Medical reversal: why we must raise the bar before adopting new technologies. Yale J Biol Med. 2011; 84(4): 471-478.
7. Ioannidis JA. Contradicted and initially stronger effects in highly cited clinical research. JAMA. 2005;294(2): 218-228.
8. Cassel CK, Guest JA. Choosing wisely: helping physicians and patients make smart decisions about their care. JAMA. 2012; 307(17): 1801-1802.
9. Brody H. Medicine's ethical responsibility for health care reformdthe top five list. N Engl J Med. 2010;362(4): 283-285.
10. Garner S, Littlejohns P. Disinvestment from low value clinical interventions: NICEly done? BMJ. 2011;343:d4519.
11. Elshaug AG, Watt AM, Mundy L, Willis CD. Over 150 potentially low-value health care practices: an Australian study. Med J Aust. 2012;197(10): 556-560.
12. Grady D, Redberg RF. Less is more: how less health care can result in better health. Arch Intern Med. 2010;170(9): 749-750.
13. Top Publications Health & Medical Sciences. http://scholar. google.com/citations?view-op=top-venues&hl=en&vq=med. Accessed June 30, 2011.
14. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006;354(4): 353-365.
15. Schneeweiss S, Seeger JD, Landon J, Walker AM. Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med. 2008;358(8): 771-783.
16. Shaw AD, Stafford-Smith M, White WD, et al. The effect of aprotinin on outcome after coronary-artery bypass grafting. N Engl J Med. 2008;358(8): 784-793.
17. Fergusson DA, Hébert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358(22): 2319-2331.
18. Roy D, Talajic M, Nattel S, et al; Atrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med. 2008;358(25): 2667-2677.
19. Van Gelder IC, Hagens VE, Bosker HA, et al; Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;347(23): 1834-1840.
20. Wyse DG, Waldo AL, DiMarco JP, et al; The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347(23): 1825-1833.
21. Solomon SD, McMurray JJV, Pfeffer MA, et al; Adenoma Prevention with Celecoxib (APC) Study Investigators. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005;352(11): 1071-1080.
22. Nussmeier NA, Whelton AA, Brown MT, et al. Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med. 2005;352(11): 1081-1091.
23. Bresalier RS, Sandler RS, Quan H, et al; Adenomatous Polyp Prevention on Vioxx (APPROVe) Trial Investigators. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med. 2005;352(11): 1092-1102.
24. Paradise JL, Feldman HM, Campbell TF, et al. Effect of early or delayed insertion of tympanostomy tubes for persistent otitis media on developmental outcomes at the age of three years. N Engl J Med. 2001;344(16): 1179-1187.
25. American Academy of OtolaryngologyeHead and Neck Surgery 2000 Clinical Indicators Compendium. Alexandria, VA: American Academy of OtolaryngologyeHead and Neck Surgery; 2000:10.
26. Paradise JL, Campbell TF, Dollaghan CA, et al. Developmental outcomes after early or delayed insertion of tympanostomy tubes. N Engl J Med. 2005;353(6): 576-586.
27. Paradise JL, Feldman HM, Campbell TF, et al. Tympanostomy tubes and developmental outcomes at 9 to 11 years of age. N Engl J Med. 2007;356(3): 248-261.
28. Hays J, Ockene JK, Brunner RL, et al; Women's Health Initiative Investigators. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med. 2003;348(19): 1839-1854.
29. Hodis HN, Mack WJ, Azen SP, et al; Women's Estrogen- Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial Research Group. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N Engl J Med. 2003;349(6): 535-545.
30. Manson JE, Hsia J, Johnson KC, et al; Women's Health Initiative Investigators. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003;349(6): 523-534.
31. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wheeler AP, Bernard GR, Thompson BT, et al. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med. 2006;354(21): 2213-2224.
32. Gerstein HC, Miller ME, Byington RP, et al; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008; 358(24): 2545-2559.
33. Patel A, MacMahon S, Chalmers J, et al; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008; 358(24): 2560-2572.
34. Hochman JS, Lamas GA, Buller CE, et al; Occluded Artery Trial Investigators. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006;355(23): 2395-2407.
35. Boden WE, O'Rourke RA, Teo KK, et al; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15): 1503-1516.
36. Mark DB, Pan W, Clapp-Channing NE, et al; Occluded Artery Trial Investigators. Quality of life after late invasive therapy for occluded arteries. N Engl J Med. 2009;360(8): 774-783.
37. Kastelein JJ, Akdim F, Stroes ES, et al; ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med. 2008;358(14): 1431-1443.
38. Taylor AJ, Villines TC, Stanek EJ, et al. Extended-release niacin or ezetimibe and carotid intima-media thickness. N Engl J Med. 2009;361(22): 2113-2122.
39. Moseley JB, O'Malley K, Petersen NJ, et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2002;347(2): 81-88.
40. Kirkley A, Birmingham TB, Litchfield RB, et al. A randomized trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2008;359(11): 1097-1107.
41. Kallmes DF, Comstock BA, Heagerty PJ, et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med. 2009;361(6): 569-579.
42. Buchbinder R, Osborne RH, Ebeling PR, et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med. 2009;361(6): 557-568.
43. De Bruin JL, Baas AF, Buth J, et al; DREAM Study Group. Longterm outcome of open or endovascular repair of abdominal aortic aneurysm. N Engl J Med. 2010;362(20): 1881-1889.
44. Fraser WD, Hofmeyr J, Lede R, et al; Amnioinfusion Trial Group. Amnioinfusion for the prevention of the meconium aspiration syndrome. N Engl J Med. 2005;353(9): 909-917.
45. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004;350(14): 1387-1397.
46. Andriole GL, Crawford ED, Grubb RL, et al; PLCO Project Team. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360(13): 1310-1319.
47. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351(27): 2795-2804.
48. Harding GK, Zhanel GG, Nicolle LE, Cheang M; Manitoba Diabetes Urinary Tract Infection Study Group. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. N Engl J Med. 2002;347(20): 1576-1583.
49. Patterson JE, Andriole VT. Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am. 1997;11(3): 735-750.
50. US Preventive Services Task Force. Screening for asymptomatic bacteriuria, hematuria and proteinuria. Am Fam Phys. 1990; 42(2): 389-395.
51. Tallman MS, Gray R, Robert NJ, et al. Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer. N Engl J Med. 2003;349(1): 17-26.
52. Somlo G, Doroshow JH, Forman SJ, et al. High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival. J Clin Oncol. 1997;15(8): 2882-2893.
53. Tomas JF, Perez-Carrion R, Escudero A, Lopez-Lorenzo JL, Lopez-Pascual J, Fernandez-Ranada JM. Results of a pilot study of 40 patients using high-dose therapy with hematopoietic rescue after standard-dose adjuvant therapy for high-risk breast cancer. Bone Marrow Transplant. 1997;19(4): 331-336.
54. Woodcock A, Forster L, Matthews E, et al; Medical Research Council General Practice Research Framework. Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma. N Engl J Med. 2003;349(3): 225-236.
55. Terreehorst I, Hak E, Oosting AJ, et al. Evaluation of impermeable covers for bedding in patients with allergic rhinitis. N Engl J Med. 2003;349(3): 237-246.
56. Ad Hoc Working Group on Environmental Allergens and Asthma. Position statement. Environmental allergen avoidance in allergic asthma. J Allergy Clin Immunol. 1999;103(2, pt 1): 203-205.
57. Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5, suppl): S147-S334.
58. Strupp M, Zingler VC, Arbusow V, et al. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med. 2004;351(4): 354-361.
59. Baloh RW. Clinical practice: vestibular neuritis. N Engl J Med. 2003;348(11): 1027-1032.
60. Todd MM, Hindman BJ, Clarke WR, Torner JC; Intraoperative Hypothermia for Aneurysm Surgery Trial (IHAST) Investigators. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med. 2005;352(2): 135-145.
61. Pemberton PL, Dinsmore J. The use of hypothermia as a method of neuroprotection during neurosurgical procedures and after traumatic brain injury: a survey of clinical practice in Great Britain and Ireland. Anaesthesia. 2003;58(4): 371-373.
62. Gibbons RJ, Abrams J, Chatterjee K, et al; American College of Cardiology; American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). ACC/AHA 2002 guideline update for the management of patients with chronic stable anginaesummary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol. 2003; 41(1): 159-168.
63. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention. ACC/AHA/ SCAI 2005 Guideline Update for Percutaneous Coronary Interventionesummary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006;113(1): 156-175.
64. Mastenbroek S, Twisk M, van Echten-Arends J, et al. In vitro fertilization with preimplantation genetic screening. N Engl J Med. 2007;357(1): 9-17.
65. Wilton L. Preimplantation genetic diagnosis for aneuploidy screening in early human embryos: a review. Prenat Diagn. 2002;22(6): 512-518.
66. Sermon KD, Michiels A, Harton G, et al. ESHRE PGD Consortium data collection VI: cycles from January to December 2003 with pregnancy follow-up to October 2004. Hum Reprod. 2007;22(2): 323-336.
67. Verlinsky Y, Cohen J, Munne S, et al. Over a decade of experience with preimplantation genetic diagnosis: a multicenter report. Fertil Steril. 2004;82(2): 292-294.
68. Action to Control Cardiovascular Risk in Diabetes Study Group; Gerstein HC, Miller ME, Byinton RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24): 2545-2559.
69. American Diabetes Association. Standards of medical care in diabetese2007. Diabetes Care. 2007;30(suppl 1):S4-S41.
70. ASTRAL Investigators; Wheatley K, Ives N, Gray R, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361(20): 1953-1962.
71. Kalra PA, Guo H, Kausz AT, et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005; 68(1): 293-301.
72. Bennett-Guerrero E, Pappas TN, Koltun WA, et al; SWIPE 2 Trial Group. Gentamicin-collagen sponge for infection prophylaxis in colorectal surgery. N Engl J Med. 2010;363(11): 1038-1049.
73. Rutten HJ, Nijhuis PH. Prevention of wound infection in elective colorectal surgery by local application of a gentamicincontaining collagen sponge. Eur J Surg Suppl. 1997;578: 31-35.
74. Lennmarken C, Bildfors K, Enlund G, Samuelsson P, Sandin R. Victims of awareness. Acta Anaesthesiol Scand. 2002;46(3): 229-231.
75. Myles PS, Leslie K, McNeil J, Forbes A, Chan MTV. Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial. Lancet. 2004; 363(9423): 1757-1763.
76. Puri GD, Murthy SS. Bispectral index monitoring in patients undergoing cardiac surgery under cardiopulmonary bypass. Eur J Anaesthesiol. 2003;20(6): 451-456.
77. Lang J. Awakening. The Atlantic. January/February 2013.
78. Avidan MS, Zhang L, Burnside BA, et al. Anesthesia awareness and the bispectral index. N Engl J Med. 2008;358(11): 1097-1108.
79. Hall JB. Use of the pulmonary artery catheter in critically ill patients: was invention the mother of necessity? JAMA. 2000; 283(19): 2577-2578.
80. Tatsioni A, Bonitsis NG, Ioannidis JP. Persistence of contradicted claims in the literature. JAMA. 2007;298(21): 2517-2526.
81. What conclusions has Clinical Evidence drawn about what works, what doesn't based on randomised controlled trial evidence? http://clinicalevidence. bmj.com/x/set/static/cms/efficacycategorisations. html. Accessed June 30, 2011.
82. Prasad V, Cifu A. A medical burden of proof: towards a new ethic. Biosocieties. 2012: 772-787.
83. Prasad V, Rho J, Cifu A. The diagnosis and treatment of pulmonary embolism: a metaphor for medicine in the evidence-based medicine era. Arch Intern Med. 2012;172(12): 955-958.
84. Prasad V, Rho J, Cifu A. The inferior vena cava filter: how could a medical device be so well accepted without any evidence of efficacy? JAMA Intern Med. 2013;173(7): 493-495.
85. Kozauer N, Katz R. Regulatory innovation and drug development for early-stage Alzheimer's disease. N Engl J Med. 2013; 368(13): 1169-1171.
86. Confavreux C, Suissa S, Saddier P, Bourdès V, Vukusic S; Vaccines in Multiple Sclerosis Study Group. Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med. 2001;344(5): 319-326.
87. Ascherio A, Zhang SM, Hernán MA, et al. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med. 2001; 344(5): 327-332.
88. Fine LG, Barnett EV, Danovitch GM, et al. Systemic lupus erythematosus in pregnancy. Ann Intern Med. 1981;94(5): 667-677.
89. Sánchez-Guerrero J, Uribe AG, Jiménez-Santana L, et al. A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med. 2005;353(24): 2539-2549.
90. Petri M, Kim MY, Kalunian KC, et al; OC-SELENA Trial. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005;353(24): 2550-2558.
91. Goetzl LM; ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists Number 36, July 2002. Obstetric analgesia and anesthesia. Obstet Gynecol. 2002;100(1): 177-191.
92. Wong CA, Scavone BM, Peaceman AM, et al. The risk of cesarean delivery with neuraxial analgesia given early versus late in labor. N Engl J Med. 2005;352(7): 655-665.
93. Koo HL, Koo DC, Musher DM, DuPont HL. Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis. Clin Infect Dis. 2009;48(5): 598-605.
94. Ioannidis JPA. Why most published research findings are false. PLoS Med. 2005;2(8):e124.